Price$0.89+0.04 (+4.46%)
01:30 PM07:45 PM
News · 26 weeks30+38%
2025-11-022026-04-26
Mix2090d
- Insider8(40%)
- SEC Filings6(30%)
- Earnings3(15%)
- Other2(10%)
- Leadership1(5%)
Latest news
25 items- PRMyomo to Report First Quarter 2026 Financial Results on May 7Myomo, Inc. (NYSE:MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that it will report financial results for the first quarter ended March 31, 2026 on Thursday, May 7, 2026. Management will hold a conference call beginning at 4:30 p.m. Eastern time to review the results, provide a business update and answer questions. Participants are encouraged to pre-register for the conference call using this link to receive a dial-in number and PIN to bypass the live operator. Participants may pre-register at any time, including up to and after the call star
- SECAmendment: SEC Form 10-K/A filed by Myomo Inc.10-K/A - MYOMO, INC. (0001369290) (Filer)
- PRMyomo Introduces Myomo Mobile App to Enhance Clinical Workflow and Patient EngagementMyomo, Inc. (NYSE:MYO), a wearable medical robotics company that offers increased functionality for people with neurological disorders and upper-limb paralysis, announces the launch of the Myomo® Mobile App, a new digital tool designed to support clinicians and patients throughout the MyoPro® experience. The Myomo Mobile App is designed to make MyoPro care more intuitive, more connected, and more data-informed. For clinicians, the app provides a streamlined mobile interface for customizing EMG settings in person or remotely, including gain, threshold, range of motion, and advanced settings. It also gives clinicians visibility into patient usage and device configurations, helping support m
- INSIDERSEC Form 4 filed by Febbo William J4 - MYOMO, INC. (0001369290) (Issuer)
- INSIDERSEC Form 3 filed by new insider Febbo William J3 - MYOMO, INC. (0001369290) (Issuer)
- SECMyomo Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits8-K - MYOMO, INC. (0001369290) (Filer)
- PRMyomo Appoints William J Febbo to its Board of DirectorsMyomo, Inc. (NYSE:MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced the appointment of William "Will" Febbo as a director effective April 14, 2026, to serve until the 2028 annual meeting of stockholders. With this appointment, Myomo has six directors. Mr. Febbo is an accomplished executive, entrepreneur, and investor with over 30 years of experience in healthcare, financial services, and technology-driven businesses. He has successfully guided organizations through substantial growth, strategic transformations and acquisitions, and significant ca
- INSIDERAmendment: SEC Form 4 filed by Gudonis Paul R4/A - MYOMO, INC. (0001369290) (Issuer)
- INSIDERSEC Form 4 filed by Henry David A4 - MYOMO, INC. (0001369290) (Issuer)
- INSIDERSEC Form 4 filed by Gudonis Paul R4 - MYOMO, INC. (0001369290) (Issuer)
- SECSEC Form 144 filed by Myomo Inc.144 - MYOMO, INC. (0001369290) (Subject)
- INSIDERDirector Getz Heather C bought $13,972 worth of shares (20,000 units at $0.70), increasing direct ownership by 18% to 131,754 units (SEC Form 4)4 - MYOMO, INC. (0001369290) (Issuer)
- INSIDERDirector Kirk Thomas F bought $51,113 worth of shares (72,000 units at $0.71), increasing direct ownership by 15% to 553,857 units (SEC Form 4)4 - MYOMO, INC. (0001369290) (Issuer)
- INSIDERDirector Getz Heather C bought $50,960 worth of shares (70,000 units at $0.73), increasing direct ownership by 168% to 111,754 units (SEC Form 4)4 - MYOMO, INC. (0001369290) (Issuer)
- SECSEC Form S-8 filed by Myomo Inc.S-8 - MYOMO, INC. (0001369290) (Filer)
- SECSEC Form 10-K filed by Myomo Inc.10-K - MYOMO, INC. (0001369290) (Filer)
- SECMyomo Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - MYOMO, INC. (0001369290) (Filer)
- PRMyomo Reports Fourth Quarter and Full Year 2025 Financial and Operating ResultsFourth quarter revenue of $11.4 million, full year revenue of $40.9 million 42% of fourth quarter revenue from recurring patient sources Record 241 authorizations and orders in the quarter Introduces 2026 revenue guidance of $43 million to $46 million as Company emphasizes recurring sources of revenue Conference call begins today at 4:30pm Eastern time Myomo, Inc. (NYSE:MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today reported financial results for the three months and year ended December 31, 2025. "We delivered 2025 revenue at the midpoint of o
- PRMyomo and Elevance Health Agree to Contract for Multi-State Network ParticipationMyomo, Inc. (NYSE:MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, announced today it has entered into its first among a series of expected network participation agreements with Elevance Health. The contracts, which include the Anthem-affiliated Commercial, Medicare Advantage, and Medicaid plans are expected to become effective on a market-by-market basis through the second quarter of 2026. Once complete, the addition of these 45 million medical members will bring Myomo's total number of covered lives under commercial insurance plans to over 80 million. These a
- PRMyomo to Report Fourth Quarter 2025 Financial Results on March 9Myomo, Inc. (NYSE:MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that it will report financial results for the fourth quarter and year ended December 31, 2025 on Monday, March 9, 2026. Management will hold a conference call beginning at 4:30 p.m. Eastern time to review the results, provide a business update and answer questions. Participants are encouraged to pre-register for the conference call using this link to receive a dial-in number and PIN to bypass the live operator. Participants may pre-register at any time, including up to and after
- INSIDERChief Executive Officer Gudonis Paul R was granted 11,637 shares, increasing direct ownership by 0.93% to 1,260,650 units (SEC Form 4)4 - MYOMO, INC. (0001369290) (Issuer)
- INSIDERChief Financial Officer Henry David A was granted 8,727 shares, increasing direct ownership by 2% to 436,627 units (SEC Form 4)4 - MYOMO, INC. (0001369290) (Issuer)
- SECMyomo Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits8-K - MYOMO, INC. (0001369290) (Filer)
- INSIDERDirector Kirk Thomas F bought $5,355 worth of shares (7,437 units at $0.72), increasing direct ownership by 2% to 481,857 units (SEC Form 4)4 - MYOMO, INC. (0001369290) (Issuer)
- INSIDERDirector Crowley Thomas Aloysius Jr. bought $3,233 worth of shares (4,385 units at $0.74), increasing direct ownership by 6% to 75,748 units (SEC Form 4)4 - MYOMO, INC. (0001369290) (Issuer)
MYO FAQ
7 questionsWhat does Myomo Inc. do?
Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living. Its products are designed to restore function in adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders. The...Where does MYO stock trade?
Myomo Inc. (MYO) is listed on AMEX.What sector and industry is MYO in?
Myomo Inc. operates in the Health Care sector, Industrial Specialties industry.When did Myomo Inc. go public?
Myomo Inc. (MYO) completed its IPO in 2017.What are analysts saying about MYO?
Myomo Inc. has had 3 recent analyst actions on file. The most recent action was from Craig Hallum: Buy with a $700.00 price target on 2024-07-31. Recent price targets range from $650.00 to $700.00.What companies are similar to MYO?
Notable peers in the same industry include ISRG (Intuitive Surgical Inc.), EW (Edwards Lifesciences Corporation), STE (STERIS plc (Ireland)), ZBH (Zimmer Biomet Holdings Inc.), MAS (Masco Corporation). Compare MYO side-by-side with any of them on Quantisnow.How can I track MYO on Quantisnow?
Quantisnow aggregates Myomo Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow MYO to receive live email and push alerts on every new disclosure.